---
title: Dipharma vs Kincell Bio
slug_a: dipharma
slug_b: kincellbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/dipharma/kincellbio
---

# Dipharma vs Kincell Bio

Side-by-side profile data from each company listing on this directory.

## Dipharma

- Profile: [/companies/dipharma](/companies/dipharma)

Dipharma — Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.

Services: 6. Modalities: 1. Indications: 0. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- API Synthesis & Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Kincell Bio

- Profile: [/companies/kincellbio](/companies/kincellbio)

Kincell Bio — Leading cell therapy CDMO delivering GMP manufacturing, analytics, and CMC strategy from early development through commercial launch across purpose-built U.S. facilities.

Services: 5. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)